ADENOSINE RECEPTORS IN RAT-BRAIN SYNAPTOSOMES - RECEPTOR CHARACTERIZATION AND RELATIONSHIPS WITH GLUTAMATE RELEASE

被引:3
|
作者
DAGANI, F [1 ]
CATTABENI, F [1 ]
CANEVARI, L [1 ]
FERRARI, R [1 ]
CAMISA, M [1 ]
ABBRACCHIO, MP [1 ]
机构
[1] UNIV MILAN,FAC SCI,IST FARMACOL,I-20122 MILAN,ITALY
关键词
MODULATING GLUTAMATE; PATHOLOGICAL NEURO-TRANSMISSION; NEURO-SECRETION;
D O I
10.1002/ddr.430280331
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The role of adenosine receptor(s) activation in modulating glutamate release in synaptosomes isolated from different rat brain areas was investigated. Receptor binding studies with selective A1 and A2 adenosine receptor ligands were performed in parallel with functional studies on depolarization-induced increases of intrasynaptosomal calcium concentrations and glutamate release. Specific binding to the selective A1 ligand [H-3]-Cyclohexyladenosine was detected, with highest densities in hippocampal synaptosomes, followed by c. striatum and cortex. In contrast, no specific binding to the selective A2a ligand [H-3]CGS 21680 was demonstrable in synaptosomes from any of the studied brain areas, suggesting that no adenosine receptors belonging to this receptor subtype are present on rat brain pre-synaptic terminals. In parallel, the adenosine analogue cyclopentyladenosine (CPA) could partially inhibit the KCl-induced glutamate release from hippocampal synaptosomes. The agonist-induced effect was monophasic, dose-dependent, and already demonstrable at the 10(-8) M concentration, which indeed confirms that only A1 receptors inhibitory on calcium-dependent release are functionally present in synaptosomal preparations. The effect on glutamate release was likely due to the ability of CPA to partially counteract KCl-induced increases of intrasynaptosomal calcium concentrations. It is therefore concluded that rat hippocampal synaptosomes represent an adequate in vitro model to study the molecular and functional correlates of pre-synaptic adenosine receptors, and therefore investigate their role in both physiological and ischemia-associated pathological neurotransmission.
引用
收藏
页码:359 / 363
页数:5
相关论文
共 50 条
  • [41] DISTRIBUTION AND RELEASE OF ADENOSINE-TRIPHOSPHATE IN RAT-BRAIN
    WU, PH
    PHILLIS, JW
    NEUROCHEMICAL RESEARCH, 1978, 3 (05) : 563 - 571
  • [42] THE CHARACTERIZATION AND LOCALIZATION OF THE GLUTAMATE RECEPTOR SUBUNIT GLUR1 IN THE RAT-BRAIN
    ROGERS, SW
    HUGHES, TE
    HOLLMANN, M
    GASIC, GP
    DENERIS, ES
    HEINEMANN, S
    JOURNAL OF NEUROSCIENCE, 1991, 11 (09): : 2713 - 2724
  • [44] CHARACTERIZATION OF THE SOLUBILIZED ADENOSINE-A1-RECEPTOR FROM RAT-BRAIN MEMBRANES
    KLOTZ, KN
    LOHSE, MJ
    SCHWABE, U
    JOURNAL OF NEUROCHEMISTRY, 1986, 46 (05) : 1528 - 1534
  • [45] RELEASE OF IMMUNOREACTIVE CHOLECYSTOKININ-OCTAPEPTIDE FROM RAT-BRAIN SYNAPTOSOMES
    SHEPPARD, MC
    KLAFF, L
    HUDSON, A
    TYLER, M
    JOURNAL OF ENDOCRINOLOGY, 1980, 87 (02) : P60 - P60
  • [46] PHORBOL ESTER ENHANCEMENT OF NEUROTRANSMITTER RELEASE FROM RAT-BRAIN SYNAPTOSOMES
    NICHOLS, RA
    HAYCOCK, JW
    WANG, JKT
    GREENGARD, P
    JOURNAL OF NEUROCHEMISTRY, 1987, 48 (02) : 615 - 621
  • [47] INTERFERENCE OF METHYL MERCURY WITH MONOAMINE UPTAKE AND RELEASE IN RAT-BRAIN SYNAPTOSOMES
    KOMULAINEN, H
    TUOMISTO, J
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1981, 48 (03): : 214 - 222
  • [48] AUTORADIOGRAPHIC CHARACTERIZATION OF HIGH-AFFINITY ADENOSINE-A2 RECEPTORS IN THE RAT-BRAIN
    JARVIS, MF
    JACKSON, RH
    WILLIAMS, M
    BRAIN RESEARCH, 1989, 484 (1-2) : 111 - 118
  • [49] Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes
    Marchi, M
    Raiteri, L
    Risso, F
    Vallarino, A
    Bonfanti, A
    Monopoli, A
    Ongini, E
    Raiteri, M
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (03) : 434 - 440
  • [50] DEPOLARIZATION-EVOKED RELEASE OF N-ACETYL-L-ASPARTYL-L-GLUTAMATE FROM RAT-BRAIN SYNAPTOSOMES
    PITTALUGA, A
    BARBEITO, L
    SERVAL, V
    GODEHEU, G
    ARTAUD, F
    GLOWINSKI, J
    CHERAMY, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 158 (03) : 263 - 266